<!DOCTYPE html>
<!--[if lt IE 7]><html class="no-js ie6 oldie ieall" lang="en" xmlns="http://www.w3.org/1999/xhtml"><![endif]-->
<!--[if IE 7]><html class="no-js ie7 oldie ieall" lang="en" xmlns="http://www.w3.org/1999/xhtml"><![endif]-->
<!--[if IE 8]><html class="no-js ie8 oldie ieall" lang="en" xmlns="http://www.w3.org/1999/xhtml"><![endif]-->
<!--[if IE 9]><html class="no-js ie9 ieall" lang="en" xmlns="http://www.w3.org/1999/xhtml"><!<![endif]-->
<!--[if (gt IE 9)|(gt IEMobile 7)|!(IEMobile)|!(IE)]><!--><html class="no-js" lang="en" xmlns="http://www.w3.org/1999/xhtml"><!--<![endif]-->
<head>
       
<script type="text/javascript">window.NREUM||(NREUM={});NREUM.info={"beacon":"beacon-1.newrelic.com","errorBeacon":"jserror.newrelic.com","licenseKey":"c2a5bf7b54","applicationID":"2502042","transactionName":"IlheTBRdCQ8DQxxWWg9DVVYSHRUWBF1aVmoSX19P","queueTime":0,"applicationTime":270,"ttGuid":"","agentToken":null,"agent":"js-agent.newrelic.com/nr-309.min.js","extra":""}</script>
<script type="text/javascript">window.NREUM||(NREUM={}),__nr_require=function a(b,c,d){function e(f){if(!c[f]){var g=c[f]={exports:{}};b[f][0].call(g.exports,function(a){var c=b[f][1][a];return e(c?c:a)},g,g.exports,a,b,c,d)}return c[f].exports}for(var f=0;f<d.length;f++)e(d[f]);return e}({"4O2Y62":[function(a,b){function c(a,b){var c=d[a];return c?c.apply(this,b):(e[a]||(e[a]=[]),void e[a].push(b))}var d={},e={};b.exports=c,c.queues=e,c.handlers=d},{}],handle:[function(a,b){b.exports=a("4O2Y62")},{}],YLUGVp:[function(a,b){function c(){var a=m.info=NREUM.info;if(a&&a.agent&&a.licenseKey&&a.applicationID){m.proto="https"===l.split(":")[0]||a.sslForHttp?"https://":"http://",g("mark",["onload",f()]);var b=i.createElement("script");b.src=m.proto+a.agent,i.body.appendChild(b)}}function d(){"complete"===i.readyState&&e()}function e(){g("mark",["domContent",f()])}function f(){return(new Date).getTime()}var g=a("handle"),h=window,i=h.document,j="addEventListener",k="attachEvent",l=(""+location).split("?")[0],m=b.exports={offset:f(),origin:l};i[j]?(i[j]("DOMContentLoaded",e,!1),h[j]("load",c,!1)):(i[k]("onreadystatechange",d),h[k]("onload",c)),g("mark",["firstbyte",f()])},{handle:"4O2Y62"}],loader:[function(a,b){b.exports=a("YLUGVp")},{}]},{},["YLUGVp"]);</script>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta name="keywords" content="newsletter, biotechnology, biodefense, robert house, dynport, science, biotech events, news, government contracting, pandemic, medical countermeasures" />
  <meta name="description" content="Where to find the latest on biodefense and emerging diseases, plus biotech news and events" />
  <meta name="geo.region" content="US" />
  <meta content="article" property="og:type" />
  <meta content="The latest on biodefense: Must-know resources" property="og:title" />
  <meta content="Where to find the latest on biodefense and emerging diseases, plus biotech news and events" property="og:description" />
  <meta content="http://www.csc.com/dvc/blog/41185/89381-the_latest_on_biodefense_must_know_resources" property="og:url" />
  <meta content="en-US" property="og:locale" />
  <meta content="Computer Sciences Corporation" property="og:site_name" />
  <link rel="canonical" href="89381-the_latest_on_biodefense_must_know_resources.html" />
  <title>The latest on biodefense: Must-know resources | CSC</title>

  <script type="text/javascript">
    var responsive=true ;
  </script>


    <script type="text/javascript">
      var responsive = true;
    </script>
    <!--[if lte IE 8]>
      <script type="text/javascript">responsive = false;</script>
    <![endif]-->
    <![if gt IE 8]>
    <meta name="viewport" content="initial-scale=1,maximum-scale=1,width=device-width" />
     <link href="../../../stylesheets/user/global-bundle-78733079cb421825fca5a903046c770c.css" media="all" rel="stylesheet" type="text/css" />
    <![endif]>
    <!--[if lte IE 8]>
       <link href="../../../stylesheets/user/global_non_responsive-bundle-9ef563e134b588f9a45b5060ad4b78aa.css" media="all" rel="stylesheet" type="text/css" />
    <![endif]-->
    

       <link href="../../../assets/public/comments-7c37505c1a6e388ce4e34a78fbb12494.css" media="screen" rel="stylesheet" type="text/css" />
    <link href="../../../stylesheets/user/blogdetail-492cb34d506631f042187b0a924bc649.css" media="all" rel="stylesheet" type="text/css" />

    <![if gt IE 8]>
    <script src="../../../javascripts/user/global-bundle-8889b0584423b7383dba5816ff101fd5.js" type="text/javascript"></script>
    <![endif]>
    <!--[if lte IE 8]>
      <script src="../../../javascripts/user/global_non_responsive-bundle-8385e9848036be955101f89324885409.js" type="text/javascript"></script>
    <![endif]-->
    


  <!--[if lt IE 9]>
  <script src="../../../javascripts/user/printshiv-min-68e071550e9b2f652850bf54693181a1.js" type="text/javascript"></script>
  <!<![endif]-->

<script>
$csc().gigya.init("2_znZ6oKy7notCLVoNArGFVv8LPRNmj8f3YN1TN-Hxt0Q1xFL2-tD8kc84bP_jARhA");
</script>


  <script type="text/javascript">
    include_default_css = true;
    //translations
    ls_header = "CSC Live Search: Quick Results";
    ls_see = "Don't see what you're looking for?";
          ls_search = "Search all over";
    ls_results = "for more results";
    mn_navigation = "Navigation";
    mn_countrySelect = "Worldwide";
    mn_search = "Search";
  </script>

  
</head>
<body itemscope itemtype="http://schema.org/WebPage">
    <script src="../../../javascripts/user/mbox_js-min-c4e062b0e669784dee7d810bbaa1f418.js" type="text/javascript"></script>
  <script type="text/javascript">
          setupCampaignTracking();
          var s_code = null;
          var _gaq = null;
          visitorOrg = null;
          var db_err = null;
        </script>
    <script src="../../../javascripts/user/s_code-min-38fd02ddea4b57c76bed86493f62daa0.js" type="text/javascript"></script>
  
  <script type="text/javascript">
    var contentID = '';
    var zoneID = '';
    var contentTypeID = '';
    s.charSet="UTF-8";
    s.pageName="DVC LLC:Blogs:DVC News for Partners:89381-The latest on biodefense Must-know resources";
    s.channel=window.location.hostname;
    s.products="89381";
    s.prop1="DVC LLC";
    s.prop2="DVC LLC:Blogs";
    s.prop3="DVC LLC:Blogs:DVC News for Partners";
    s.prop8="Blogs";
    s.prop9="89381";
    s.prop10="1819";
    s.prop16="Managed Multipurpose Sites";
    s.prop19="";
    s.prop37="Zack Cannon";
    s.prop38="Awareness";
    s.eVar44 = "D=c38";
    s.prop41="TDM";
    s.eVar46 = "D=c41";
    contentID="89381";
    zoneID = "265";
    contentTypeID = "17";
    s.eVar9="D=c1";
    s.eVar10="D=c16";
    s.eVar11="Blogs";
    s.eVar12="D=pageName";
    s.eVar13="D=c19";
    s.eVar45="D=c37";
    s.eVar8="D=c9";
    
    s.prop12 = document.location.pathname + document.location.search;
    s.prop13="en-US";
    s.hier1 = document.location.hostname + ':' + s.pageName;
    createPublicPage(contentID,contentTypeID,s.prop8,zoneID,s.prop1,s.prop19);


    $csc().analytics.visitorOrg.buildPublic();
    _gaq = _gaq || [];
   setupGA(_gaq);

  </script>

  <script type="text/javascript">
  <!-- if(navigator.appVersion.indexOf('MSIE')>=0)document.write(unescape('%3C')+'\!-'+'-') //-->
  </script>
  <noscript>
  <a href="http://www.omniture.com">
    <img src="http://computersciences.112.2o7.net/b/ss/csccom/1/H.15.1--NS/0" height="1" width="1" style="border: 0;" alt="" />
  </a>
  </noscript>

  <div class='mboxDefault'></div>
  <script type='text/javascript'>
  mboxCreate('page',
'entity.id=89381',
'entity.name=The latest on biodefense: Must-know resources',
'entity.pageURL=/dvc/blog/41185/89381-the_latest_on_biodefense_must_know_resources',
'entity.message=Where to find the latest on biodefense and emerging diseases, plus biotech news and events',
'entity.categoryId=265',
'entity.content_type_id=17',
'entity.thumbnailURL=',
'entity.key_content_type=0',
'entity.locale=en-US',
'entity.listing=0',
'user.categoryId=265');
  </script>

<div id="viewporter">
  <header>
    <div id="mobiTagLine">
      <p>
        A global leader in providing technology enabled business solutions and services
      </p>
    </div>
    <div class="mainLogo">
      <a href="../../../index.html">
        <img src="../../../assets/new/logo.png" alt="CSC Logo - A global leader in providing technology enabled business solutions and services." /></a>
      <span class="globalHeadline">A global leader in providing technology enabled business solutions and services.</span>
    </div>
    <div id="country">
      <div><a href="javascript:void(0);" class="countryHide countrySelector">Worldwide</a><a id="countrySelector" class="countryHide countrySelector"></a></div>
      <div id="country-select" style="display:none;">
        <!--link href="/stylesheets/user/country_select_styles-min.css" rel="stylesheet" type="text/css" /-->
<div class="unitedstates">
	<a href="../../../index.html">United States</a>
</div>
<div class="australia">
	<a href="../../../au.html">Australia</a>
</div>
<div class="austria">
	<a href="../../../de.html">Austria</a>
</div>
<div class="belgium">
	<a href="../../../be.html">Belgium</a>
</div>
<div class="brazil">
	<a href="../../../br_pt.html">Brazil</a>
</div>
<div class="bulgaria">
	<a href="../../../eastern_europe.html">Bulgaria</a>
</div>
<div class="canada">
	<a href="../../../ca_en.html">Canada</a>
</div>
<div class="canada">
	<a href="../../../ca_fr.html">Canada [fr]</a>
</div>
<div class="chile">
	<a href="../../../cl.html">Chile</a>
</div>
<div class="china">
	<a href="../../../cn_cn.html">China</a>
</div>
<div class="czech">
	<a href="../../../eastern_europe.html">Czech Republic</a>
</div>
<div class="denmark">
	<a href="../../../dk.html">Denmark</a>
</div>
<div class="france">
	<a href="../../../fr.html">France</a>
</div>
<div class="germany">
	<a href="../../../de.html">Germany</a>
</div>
<div class="hongkong">
	<a href="../../../hk_en.html">Hong Kong</a>
</div>
<div class="india">
	<a href="../../../in.html">India</a>
</div>
<div class="italy">
	<a href="../../../it.html">Italy</a>
</div>
<div class="japan">
	<a href="../../../jp_jp.html">Japan</a>
</div>
<div class="korea">
	<a href="../../../kr.html">Korea</a>
</div>
<div class="lithuania">
	<a href="../../../lt.html">Lithuania</a>
</div>
<div class="luxembourg">
	<a href="../../../lu.html">Luxembourg</a>
</div>
<div class="malaysia">
	<a href="../../../my.html">Malaysia</a>
</div>
<div class="netherlands">
	<a href="../../../nl.html">Netherlands</a>
</div>
<div class="norway">
	<a href="../../../no.html">Norway</a>
</div>
<div class="poland">
	<a href="../../../eastern_europe.html">Poland</a>
</div>
<div class="portugal">
	<a href="../../../pt.html">Portugal</a>
</div>
<div class="romania">
	<a href="../../../eastern_europe.html">Romania</a>
</div>
<div class="singapore">
	<a href="../../../sg.html">Singapore</a>
</div>
<div class="slovakia">
	<a href="../../../eastern_europe.html">Slovakia</a>
</div>
<div class="southafrica">
	<a href="../../../za.html">South Africa</a>
</div>
<div class="spain">
	<a href="../../../es.html">Spain</a>
</div>
<div class="sweden">
	<a href="../../../se.html">Sweden</a>
</div>
<div class="switzerland">
	<a href="../../../de.html">Switzerland</a>
</div>
<div class="thailand">
	<a href="../../../th_en.html">Thailand</a>
</div>
<div class="unitedkingdom">
	<a href="../../../uk.html">United Kingdom</a>
</div>
<div class="vietnam">
	<a href="../../../vn_en.html">Vietnam</a>
</div>
<div class="vietnam">
	<a href="../../../vn_vn/index.html">Vietnam [vn]</a>
</div>

      </div>
      <div id="search">
        <form action="/search" method="get" name="searchForm" id="searchForm">
          <ul>
            <li>
              <input id="searchField" type="text" name="q"  />
              <input type="hidden" value="265" name="zone_id" id="gsa_zone_id" /><input type="hidden" value="en-US" name="locale" id="gsa_locale"/>
            </li>
            <li><input id="searchSubmit" class="hidden searchBtn" type="submit" /></li>
          </ul>
        </form>
      </div>
    </div>
    <nav id="mobiMainNav">
      <ul>
        <li id="mobiCountry"><a href="javascript:void(0);">&nbsp;</a> </li>
        <li id="mobiNav"><a href="javascript:void(0);">&nbsp;</a> </li>
        <li id="mobiSearchBtn"><a href="javascript:void(0);">&nbsp;</a> </li>
      </ul>
      <div id="mobileSearch" style="display:none">
        <div class="mobileSearchWrap">
          <input type="text" name="searchText" id="mobileSearchInput" /><a id="mobiSearchImage" href="javascript:void(0);"></a>
        </div>
      </div>
      <div id="mobileNav" style="display:none">
        <ul class="mobinav" style="">
	<li class="solutionsLink">
		<a href="../../offerings/44393.html">Services</a></li> 
	</li>
	<li class="successLink">
		<a href="../../ds/16190/16326-team_with_dvc.html">Partners</a></li>
	</li>
	<li class="insightsLink">
		<a href="../../ds/11646/15182-dvc_company_information.html">About Us</a></li>
	</li>
	<li class="contactLink">
		<a href="../../ds/16321/16362-job_openings.html">Careers</a></li>
	</li>
	<li class="aboutLink">
		<a href="../../contact_us.html">Contact Us</a>
	</li>
</ul>
      </div>
    </nav>
    <div id="loginSection">
      <div id="visitor_login_section" class="loginSection unhidden"><a href="javascript:void(0);" id="nav_account_create" onclick="accountPopupWindow('account_create');">Register</a><span class="nav_account_spacer">&nbsp;|&nbsp;</span><a href="javascript:void(0);" id="nav_account_login" onclick="accountPopupWindow('account_login');"><span class="nav_account_spacer">Login</span></a></div>
<div id="visitor_welcome_section" class="loginSection hidden"><span class="nav_account_spacer">Welcome,&nbsp;</span><label id="nav_edit_profile" style="cursor:pointer;" onclick="accountPopupWindow('editprofile');"><span id="visitor_name"></span></label><span class="nav_account_spacer">&nbsp;|&nbsp;</span><a href="../../../utils/logout_visitor.html" id="nav_logout_visitor">Log&nbsp;Out</a></div>
    </div>
    <div class="wrapper">
  <nav id="globalNav">
    <ul id="nav">
      <li id="solutionsLink">
	<a href="../../offerings/44393.html">Services</a></li>
      <li id="successLink">
        <a href="../../ds/16190/16326-team_with_dvc.html">Partners</a></li>
      <li id="insightsLink">
        <a href="../../ds/11646/15182-dvc_company_information.html">About Us</a></li>
      <li id="contactLink">
        <a href="../../ds/16321/16362-job_openings.html">Careers</a></li>
      <li id="aboutLink">
        <a href="../../contact_us.html">Contact Us</a>
      </li>
    </ul>
  </nav>
</div>
  </header>
  <div class="breadcrumbs wrapper" itemprop="breadcrumb">
    <ul class='breadCrumbs'> <li><a href='../../../index.html'>Home</a> / </li> <li><a href='../../../dvc.html'>DVC LLC</a> / </li> <li><a href='../41185.html'>DVC News Updates for Partners</a> / </li> <li>The latest on biodefense: Must-know resources</li> </ul>
  </div>
  <nav class="mobiSecondaryNav">
    <ul>
      <li id="mobiBack"><a href="../41185.html">Back</a> </li>
      <li id="mobiBackLabel">&nbsp;</li>
      <li id="mobiMoreLinks"><a href="javascript:void(0);">More Links</a> </li>
    </ul>
  </nav>
  <div id="iscrollWrapper">
    <div class="scrollwrap">
      <!-- Content Start -->

      
<section id="mainContent" class="rightSideBar">
  <div class="wrapper">
    
    <!-- Share Bar Plugin DIV Container -->
<div id="gigyaButtons"></div>
<script type="text/javascript">
  $csc().gigya.showShareBar();
</script>
<!-- End Share Bar Code -->
    <article class="pageContent" itemprop="mainContentOfPage">
    <!-- Gigya Bar -->
    <article class="blogPost">
    <section>
      <h1>The latest on biodefense: Must-know resources</h1>
      <time>2012-10-01</time>
      <p><h2><strong>Feature: Where to find the latest on biodefense and emerging diseases</strong></h2>
<p><a target="_blank" href="../../ds/11647/15191-biodefense_and_pandemic_resources.html"><img style="float: right; margin: 10px;" alt="Biological, radiological and chemical hazard signs on a chain link fence" src="http://assets1.csc.com/dvc/images/hazard_signs_fence.gif" height="287" width="350" /></a>Biodefense hasn’t been in the news much lately, and the media frenzy over pandemic influenza seems to have peaked a couple years ago. But if you know where to look, you’ll find plenty of resources on biodefense and pandemic preparedness.</p>
<p>A good place to start? Follow the money. Crystal Franco and Tara Kirk Sell of The Center for Biosecurity at UPMC have published an <a target="_blank" href="http://www.upmc-biosecurity.org/website/resources/publications/2012/2012-06-12-biodeffunds.html">overview of federal biodefense funding</a> for FY2012-FY2013.  One notable trend is a shift away from pure biodefense, such as anthrax and smallpox vaccines, toward countermeasures applicable to a host of diseases, naturally occurring and otherwise—a broad-spectrum approach.</p>
<p>According to the report, the U.S. government plans to spend $5.54 billion on civilian biodefense in FY2013, on both pure biodefense (less than 10% of the total funding) and “programs with multiple goals and applications, including biodefense.”</p>
<p>You can keep up with biodefense and infectious disease news with these free resources:</p>
<ul>
<li>BioSecurity News Today – <a target="_blank" href="http://www.upmc-biosecurity.org/website/biosecurity_briefing/">daily email</a> from UPMC Center for BioSecurity covering all aspects of biosecurity and biopreparedness</li>
<li>CIDRAP  – the University of Minnesota Center for Infectious Disease Research and Policy issues <a target="_blank" href="http://www.cidrap.umn.edu/cidrap/index.html">daily headline alerts</a> via email, including bioterrorism, biosecurity, influenza and food safety</li>
<li>FierceVaccines – <a target="_blank" href="http://www.fiercevaccines.com/">weekly email</a> on all types of vaccines and vaccine technology and FierceBiotech, a <a target="_blank" href="http://www.fiercebiotech.com/">daily email</a> on biotech deals, FDA approvals, clinical trials and more</li>
<li>Wired SUPERBUG blog – author Maryn McKenna follows <a target="_blank" href="http://www.wired.com/wiredscience/superbug/">emerging diseases</a></li>
</ul>
<p><a target="_blank" href="../../ds/11647/15191-biodefense_and_pandemic_resources.html"><strong>More biodefense and pandemic resources</strong></a></p>
<hr />
<h2></h2>
<h2><strong>TechWatch: Science News Tidbits</strong></h2>
<p><a target="_blank" href="http://www.sciencedaily.com/releases/2012/08/120827122258.htm?utm_source=BNT+August+28,+2012&utm_campaign=BNT082812&utm_medium=email"><img style="float: right; margin: 10px;" alt="Vitamin B tablets spilling from jar" src="http://assets1.csc.com/dvc/images/vitaminBtablets.gif" height="261" width="175" /></a><a target="_blank" href="http://www.sciencedaily.com/releases/2012/08/120827122258.htm?utm_source=BNT+August+28,+2012&utm_campaign=BNT082812&utm_medium=email">Vitamin B3 may offer new tool in fight against Staph infections, superbugs</a><br /> “A new study suggests that nicotinamide, more commonly known as vitamin B3, may be able to combat some of the antibiotic-resistance staph infections that are increasingly common around the world, have killed thousands and can pose a significant threat to public health. The research found that high doses of this vitamin increased by 1,000 times the ability of immune cells to kill staph bacteria. The work was done both in laboratory animals and with human blood. The findings were published August 27 in the Journal of Clinical Investigation by researchers from Cedars-Sinai Medical Center, the Linus Pauling Institute at Oregon State University, UCLA, and other institutions." <em>(Source: ScienceDaily)</em><br /><strong><em> JCI </em>article:</strong> <a target="_blank" href="http://www.jci.org/articles/view/62070">C/EBPε mediates nicotinamide-enhanced clearance of Staphylococcus aureus in mice</a></p>
<p><a target="_blank" href="http://www.fiercebiotechresearch.com/story/scientists-discover-wound-healing-secret/2012-08-20#ixzz24J0MEX7p">Scientists discover wound-healing secret</a><br /> "The trigger for wounds to begin healing may come to this: the interaction of a skin-cell molecule and T-cell molecule, after which damaged skin and the inner surfaces of the gut and lungs begin to repair themselves. ... In short, through lab studies with mice, Scripps' research professor Wendy Havran determined that the interaction of the plexin B2 skin-cell receptor and the CD100 receptor found on gamma delta cells is crucial to wound healing, and that cells can't fully begin their healing process if they don't have CD100 in place. In turn, using B2 molecules to stimulate CD100 helped trigger the healing process in T cells and the healing of wounds in mouse intestine linings."<em> (Source: Mark Hollmer, FierceBiotech)</em><br /><strong><em> Immunity </em>abstract</strong> (subscription required to view full text): <a target="_blank" href="http://www.cell.com/immunity/abstract/S1074-7613(12)00326-3">The CD100 Receptor Interacts with Its Plexin B2 Ligand to Regulate Epidermal γδ T Cell Function</a></p>
<p><a target="_blank" href="http://www.redorbit.com/news/health/1112677602/poxviruses-adapt-fight-defenses-081712/?utm_source=BNT+August+20,+2012&utm_campaign=BNT082012&utm_medium=email">Poxviruses adapt quickly to fight host of viral defenses</a><br /> "Researchers recently discovered how poxviruses, viruses that contain DNA, can change quickly; in particular, they have an 'accordion-like' way of viral adaption to fight against host viral defenses. Poxviruses, which include smallpox, can lead to a number of diseases in both humans and animals. They are seen as harmful, as they can pass through the species barrier with low mutation rates. ... Researchers hope to better understand the role of poxviruses to develop more effective antiviral methods. In particular, scientists at Fred Hutchinson Cancer Research Center collaborated with other institutions to determine how poxviruses change to adapt against their host defenses. The findings of the research were published in a recent edition of the journal Cell." <em> (Source: Connie K. Ho, Red Orbit)</em><br /> <strong><strong><em>Cell </em></strong>abstract </strong>(subscription required to view full text): <a target="_blank" href="http://www.cell.com/abstract/S0092-8674(12)00870-7">Poxviruses deploy genomic accordions to adapt rapidly against host antiviral defenses</a></p>
<p><a target="_blank" href="http://www.fiercebiotech.com/story/new-lab-organs-promise-faster-cheaper-better-drug-development/2012-08-20?utm_medium=nl&utm_source=internal">New lab organs promise faster, cheaper, better drug development</a><br /> "It will come as no surprise to anyone in the business of drug development and translational research to hear that animal studies suffer from severe shortcomings. The traditional mouse study often can't detect the kind of simple toxicities that will scuttle a program later on. Mouse models help, but animal biology in the lab is still far removed from human targets, one reason why we're often treated to cancer cures which never get far in human studies. Enter the organoid, stage left. A Bloomberg writer stepped in to review a "blob of tissue" being used to test new diarrhea therapies at Johns Hopkins, one of a number of organoids that promise to do the work of animals, only cheaper, faster and far more accurately. Tied to the experimental use of human cells on a chip in preclinical drug testing, and you have a highly anticipated push--largely funded by NIH--to turn translational research on its head."  <em>(Source: John Carroll, FierceBiotech)</em></p>
<hr />
<h2></h2>
<h2><strong>Industry and Government Contracting News</strong></h2>
<h3><strong>Biopharma and Biodefense</strong></h3>
<p><a target="_blank" href="http://www.cdc.gov/hantavirus/outbreaks/yosemite-national-park-2012.html"><img style="float: right; margin: 10px;" alt="A deer mouse, Peromyscus maniculatus, crouched in a sawdust, pine needle and bird feather habitat. Deer mice are the principal reservoir of Sin Nombre (SN) virus, the primary etiologic agent of hantavirus cardiopulmonary syndrome (HCPS) in North America. A relatively new acute respiratory illness, hantavirus pulmonary syndrome (HPS), was first documented in May 1993 in New Mexico. Image credit: CDC" src="http://assets1.csc.com/dvc/images/deermouse.gif" height="166" width="250" /></a>The National Park Service has reported <a target="_blank" href="http://www.cdc.gov/hantavirus/outbreaks/yosemite-national-park-2012.html">nine cases</a> of hantavirus among visitors who stayed at Yosemite National Park in California since June 2012. Three of the confirmed cases were fatal.</p>
<p><em>Image: A deer mouse, Peromyscus maniculatus, crouched in a sawdust, pine needle and bird feather habitat. Deer mice are the principal reservoir of Sin Nombre (SN) virus, the primary etiologic agent of hantavirus cardiopulmonary syndrome (HCPS) in North America. A relatively new acute respiratory illness, hantavirus pulmonary syndrome (HPS), was first documented in May 1993 in New Mexico. Image credit: CDC</em></p>
<p>As pretty as a picture (but a lot more deadly): They look like works of modern art but these <a target="_blank" href="http://www.dailymail.co.uk/sciencetech/article-2197533/As-pretty-picture-lot-deadly--Killer-diseases-youve-seen-before.html#ixzz25cyWjcE3">incredible images</a> show some of the world’s deadliest diseases.</p>
<p>New <a target="_blank" href="http://www.fiercevaccines.com/story/flu-adjuvant-adds-promise-vaccine/2012-08-27?utm_medium=nl&utm_source=internal#ixzz252ZlzsXf">adjuvant</a> adds promise to flu vaccine.</p>
<p>CDC recommends <a target="_blank" href="http://www.scientificamerican.com/article.cfm?id=cdc-recommends-booster-shoots-whooping-cough-outbreak&WT.mc_id=SA_CAT_SP_20120903&utm_source=BNT+September+5,+2012&utm_campaign=BNT090512&utm_medium=email">booster shots</a> for whooping cough outbreak.</p>
<p>Analysts show why orphan drug development is going <a target="_blank" href="http://www.fiercebiotech.com/story/analysts-show-why-orphan-drug-development-going-gangbusters/2012-08-22?utm_medium=nl&utm_source=internal#ixzz24IwDxQ6R">gangbusters</a>.</p>
<p>The FDA has <a target="_blank" href="http://www.in-pharmatechnologist.com/Regulatory-Safety/US-FDA-revises-blood-storage-and-testing-rules-for-manufacturers">revised</a> storage and testing requirements for human blood intended for transfusion or further manufacturing.</p>
<p>Researchers find alarming <a target="_blank" href="http://www.cidrap.umn.edu/cidrap/content/other/resistance/news/aug3012resistance.html">global levels</a> of drug-resistant TB. The upside: a low-cost <a target="_blank" href="http://medicalxpress.com/news/2012-09-pain-drug-resistant-tuberculosis.html">pain drug</a> has been shown to kill resistant tuberculosis. (From <em>Proceedings of the National Academy of Sciences:</em> <a target="_blank" href="http://www.pnas.org/content/early/2012/09/07/1214188109.abstract?sid=675990e3-f65d-467f-b574-14dc9857cdb6">Nonsteroidal anti-inflammatory drug sensitizes Mycobacterium tuberculosis to endogenous and exogenous antimicrobials</a>)</p>
<p>CDC reports first H3N2v death as <a target="_blank" href="http://www.cidrap.umn.edu/cidrap/content/influenza/general/news/aug3112variant.html">cases rise</a> to 290. Reconstructed 1918 influenza virus yields <a target="_blank" href="http://www.infectioncontroltoday.com/s.aspx?exp=1&u=http://www.infectioncontroltoday.com/news/2012/09/reconstructed-1918-influenza-virus-yields-key-insights-scientists-say.aspx">key insights</a>.</p>
<p><a target="_blank" href="http://www.nytimes.com/2012/09/04/health/research/new-tick-borne-heartland-virus-has-scientists-puzzled.html?_r=2ref=research&utm_source=BNT+September+4,+2012&utm_campaign=BNT090412&utm_medium=email&">New virus</a> tied to ticks poses puzzle for doctors.</p>
<p><a target="_blank" href="http://www.nytimes.com/2012/09/04/health/research/new-tick-borne-heartland-virus-has-scientists-puzzled.html?_r=1&ref=research&utm_source=BNT+September+4,+2012&utm_campaign=BNT090412&utm_medium=email"><img style="float: right; margin: 10px;" alt="Ground turmeric in a wooden spoon" src="http://assets1.csc.com/dvc/images/turmeric.gif" height="166" width="250" /></a>A <a target="_blank" href="http://www.nbcsandiego.com/news/health/Americas-No-1-Killer-May-Have-a-Kryptonite--166163016.html">vaccine</a> for heart disease?</p>
<p>Curcumin, found in the Indian spice turmeric, <a target="_blank" href="http://scienceblog.com/56128/turmeric-spices-up-virus-study/#511xcG0FyTLDhD3g.99">stopped</a> the potentially deadly Rift Valley Fever virus from multiplying in infected cells.</p>
<p>(Influenza) BARDA takes <a target="_blank" href="http://www.phe.gov/Preparedness/news/Pages/pandemic-120906.aspx?utm_source=BNT,+September+7,+2012&utm_campaign=BNT090712&utm_medium=email">historic steps</a> with master vaccine seed lots, vaccines for pre-pandemic stockpile.</p>
<p>CDC says West Nile activity may have peaked, but 2012 is still on track to be a <a target="_blank" href="http://www.cidrap.umn.edu/cidrap/content/other/wnv/news/sep1212westnile.html?utm_source=BNT+September+13,+2012&utm_campaign=BNT091312&utm_medium=email">record year</a>. While most people infected with West Nile show no symptoms, researchers are investigating the <a target="_blank" href="http://www.nature.com/news/the-hidden-threat-of-west-nile-virus-1.11436">possibility</a> that even mild infections can lead to kidney disease.</p>
<p>Does the West Nile outbreak signal an <a target="_blank" href="http://www.washingtonpost.com/national/health-science/does-the-west-nile-outbreak-signal-an-epidemic-of-viral-epidemics-yes-and-no/2012/09/12/bc8e9b34-fc14-11e1-b153-218509a954e1_story.html">epidemic</a> of viral epidemics? Yes and no.</p>
<h3><strong>Government Contracting and Business</strong></h3>
<p><strong>Funding: </strong>The <a target="_blank" href="http://www.marylandbiocenter.org/Pages/Homepage.aspx">Maryland Biotechnology Center</a> is now accepting <a target="_blank" href="http://marylandbiocenter.org/businessdevelopment/Pages/biotechnologydevelopmentgrants.aspx">applications</a> for its 2012-2013 biotechnology development awards for commercialization and translational research. Maryland organizations may apply for the awards, which range from $50,000 to $200,000. Applications are due by 5:00 p.m. <strong>October 17, 2012</strong>.</p>
<p><strong>Update on SAM: </strong>DoD <a target="_blank" href="http://www.bizjournals.com/washington/blog/fedbiz_daily/2012/09/dod-forgoes-registration-requirement.html?ana=e_wash_fedbiz&s=newsletter&ed=2012-09-10">forgoes</a> registration requirement for contractors, due to system bugs. (See our <a target="_blank" href="88290-have_you_met_sam_government_contractors_take_note.html">September edition</a> for more on SAM.)</p>
<p>The White House says contractor suspensions and debarments are <a target="_blank" href="http://cdn.govexec.com/interstitial.html?rf=http://www.govexec.com/contracting/2012/09/contractor-suspensions-and-debarments-rise-says-white-house/58175/?oref=river">on the rise</a>.</p>
<p>Agencies to strengthen contractor past performance evaluations; contractor <a target="_blank" href="http://www.bizjournals.com/washington/blog/fedbiz_daily/2012/09/agencies-to-strengthen-contractor-past.html?ana=e_wash_fedbiz&s=newsletter&ed=2012-09-06">comments accepted</a> until <strong>November 5, 2012</strong>.</p>
<p>Lessons from government contractors: <a target="_blank" href="http://www.washingtonpost.com/business/on-small-business/lessons-from-government-contractors-bid-more-and-smarter/2012/08/27/5aa06e74-ebdf-11e1-aca7-272630dfd152_story.html?wpisrc=nl_headlines_local">bid more, and smarter</a>. Related: <a target="_blank" href="http://www.bizjournals.com/washington/blog/fedbiz_daily/2012/08/patience-pays-off-in-bid-competitions.html?ana=e_wash_fedbiz&s=newsletter&ed=2012-08-17&page=all">patience pays off</a> in bid competitions.</p>
<p>Gene <a target="_blank" href="http://www.fiercebiotech.com/story/gene-patent-ruling-seen-win-myriad-biotech-industry/2012-08-17?utm_medium=nl&utm_source=internal">patent ruling</a> seen as a win for biotech industry.</p>
<p>How small businesses can <a target="_blank" href="http://www.bizjournals.com/washington/blog/fedbiz_daily/2012/09/how-small-businesses-can-manage.html?ana=e_wash_fedbiz&s=newsletter&ed=2012-09-06">manage</a> federal cuts.</p>
<p>More trial, less error: An effort to <a target="_blank" href="http://www.reuters.com/article/2012/08/14/us-science-replication-service-idUSBRE87D0FV20120814">improve</a> scientific studies.</p>
<p>Communicating science: intuitive failures.</p>
<p>India: A powerhouse of innovation for <a target="_blank" href="http://www.huffingtonpost.com/david-de-ferranti/india-health-research_b_1834709.html?utm_source=BNT+August+30,+2012&utm_campaign=BNT083012&utm_medium=email">neglected diseases</a>?</p>
<h3></h3>
<h3><strong>Reports and Resources</strong></h3>
<p><a target="_blank" href="http://www.cidrap.umn.edu/cidrap/content/bt/vhf/news/sep0412dengue.html"><img style="float: left; margin-left: 10px; margin-right: 10px;" alt="Report cover: WHO Global Strategy for Dengue Prevention and Control 2012-2020" src="http://assets1.csc.com/dvc/images/WHOdenguestrategy.gif" height="200" width="200" /></a>WHO <a target="_blank" href="http://www.cidrap.umn.edu/cidrap/content/bt/vhf/news/sep0412dengue.html">takes aim</a> at dengue in strategy document. <strong>Report:</strong> <a target="_blank" href="http://reliefweb.int/sites/reliefweb.int/files/resources/9789241504034_eng.pdf">Global Strategy for Dengue Prevention and Control 2012-2020</a> (PDF, 686 KB)</p>
<p><strong>Database:</strong> The Federal Laboratory Consortium for Technology Transfer now has an easily searchable database of federal laboratory inventions that are available for transfer to business partners.</p>
<p><strong>Comparison: </strong>Flu prescription sales data from a retail pharmacy in the U.S. with Google Flu Trends and U.S. ILINet (CDC) data as flu activity indicator, from <em>PLoS One</em>.</p>
<p>BioShield report <a target="_blank" href="http://www.cidrap.umn.edu/cidrap/content/bt/botulism/news/sep1712bioshield.html">shows growth</a> in biodefense stockpile. <strong>Report: </strong><a target="_blank" href="https://www.medicalcountermeasures.gov/media/10061/pbs_report_2011_final_9-6-2012.pdf">Project BioShield Annual Report to Congress January 2011 – December 2011</a> (PDF, 1.54MB)</p>
<p><strong><a target="_blank" href="http://www.amazon.com/gp/product/0674047702?ie=UTF8&camp=1789&creativeASIN=0674047702&linkCode=xm2&tag=washpost-books-20"><img style="float: right; margin: 10px;" alt=" Book cover: The Soviet Biological Weapons Program: A History, by Milton Leitenberg" src="http://assets1.csc.com/dvc/images/The_Soviet_Biological_Weapons_Program.gif" height="221" width="150" /></a>Report: </strong><a target="_blank" href="http://www.nap.edu/catalog.php?record_id=13516">Determining Core Capabilities in Chemical and Biological Defense Science and Technology</a></p>
<p><strong>Social media:</strong> HHS touts <a target="_blank" href="http://www.govhealthit.com/news/hhs-touts-twitter-app-public-health?utm_source=BNT+September+17,+2012&utm_campaign=BNT091712&utm_medium=email">Twitter app</a> for public health</p>
<p><strong>Book: </strong><a target="_blank" href="http://www.amazon.com/gp/product/0674047702?ie=UTF8&camp=1789&creativeASIN=0674047702&linkCode=xm2&tag=washpost-books-20">The Soviet Biological Weapons Program: A History</a> by Milton Leitenberg</p>
<p><strong>White paper:<a target="_blank" href="http://www.bio-itworld.com/uploadedFiles/Bio-IT_World/Whitepaper_SmartForms/Forms/PDF/ARX-Improving-Life-Sciences.PDF"> </a></strong><a target="_blank" href="http://www.bio-itworld.com/uploadedFiles/Bio-IT_World/Whitepaper_SmartForms/Forms/PDF/ARX-Improving-Life-Sciences.PDF">Cutting Costs, Saving Time: Improving Life Sciences Operations with Digital Signatures</a> (PDF, 1.4KB)</p>
<p><strong>Apps: </strong>10 Big Pharma <a target="_blank" href="http://www.fiercebiotechit.com/story/10-big-pharma-smartphone-apps/2012-08-20">smartphone apps</a></p>
<hr />
<h2></h2>
<h2><strong>Upcoming Events</strong></h2>
<p><strong>October 1-2, 2012, Boston, MA –</strong> 2nd Annual <a target="_blank" href="http://www.theconferenceforum.org/PartnershipOpportunitiesInDrugDelivery-Overview.html">Partnership Opportunities in Drug Development</a></p>
<p><strong>October 1-2, 2012, Berkeley, CA –</strong> 8th Annual <a target="_blank" href="http://www.iirusa.com/cba/home.xml">Bioassays &amp; Bioanalytical Method Development Conference</a></p>
<p><strong>October 4, 2012, virtual –</strong> <a target="_blank" href="https://event.on24.com/eventRegistration/EventLobbyServlet?target=registration.jsp&eventid=515796&sessionid=1&key=EA95E59AF9C37392CD0FBA6714D8769B&sourcepage=register">Webinar</a>: The Simple Western™ Approach to Vaccine and Clinical Protein Research (free, registration required)</p>
<p><strong>October 7-9, 2012, Brussels, Belgium –</strong> BioPartnering Future Europe</p>
<p><strong>October 8, 2012, San Francisco, CA – </strong>BIO <a target="_blank" href="http://www.bio.org/events/conferences/techtransfersymposium?utm_source=newsletter&utm_medium=email&utm_campaign=0711">Technology Transfer Symposium</a></p>
<p><strong>October 8-11, 2012, Baltimore, MD –</strong> <a target="_blank" href="http://www.diahome.org/en/Meetings-and-Training/Find-Meetings-and-Training/Meeting-Details.aspx?roi=echo4-19927788194-17130143-fdeda31e8323bbeac83301de02f6f240&ProductID=27425&EventType=Meeting&FlagshipMeetingFlag=False">EDM and ERS/eCTD</a>: The Content Continuum from Document Authoring through Submission Delivery</p>
<p><strong>October 8-12, 2012, Providence, RI –</strong> <a target="_blank" href="http://www.ibclifesciences.com/BPI/overview.xml">BioProcess International Conference &amp; Exhibition</a></p>
<p><strong><a target="_blank" href="http://www.amiando.com/challenges-in-malaria-research.html"><img style="float: right; margin: 5px;" alt="Basel, Switzerland Rhine river and the Middle Bridge" src="http://assets1.csc.com/dvc/images/basel_switzerland.gif" height="166" width="250" /></a>October 9-12, 2012, Cambridge, MA –</strong> <a target="_blank" href="http://www.barnettclinicalsummit.com/">Barnett Clinical Summit</a></p>
<p><strong>October 10-12, 2012, Basel, Switzerland –</strong> <a target="_blank" href="http://www.amiando.com/challenges-in-malaria-research.html">Challenges in Malaria Research</a></p>
<p><strong>October 10-12, 2012, Bethesda, MD –</strong> Immunogenicity Summit, including <a target="_blank" href="http://www.healthtech.com/Conferences_Overview.aspx?id=113590">Immunogenicity Assessment and Clinical Relevance</a> and <a target="_blank" href="http://www.healthtech.com/Conferences_Overview.aspx?id=113592">Immunogenicity Prediction and Control</a></p>
<p><strong>October 14-16, 2012, Shanghai, China – </strong><a target="_blank" href="http://www.vaccinecongress.com/index.html">6th Vaccine and ISV Congress</a></p>
<p><strong>October 22, 2012, Bethesda, MD – </strong><strong><a target="_blank" href="http://www.innovationsinclinicaltrials.com/">Transforming Drug Development</a>: Delivering Innovation and Efficiency through Adaptive Clinical Trials</strong></p>
<p><strong>October 22-23, 2012, Montgomery County, MD – </strong>3rd Annual <a target="_blank" href="http://www.techtransfersummit.com/northamerica2012/">Tech Transfer Summit North America</a></p>
<p><strong>October 22-24, 2012, Washington, DC – </strong><a target="_blank" href="http://www.diahome.org/en/Flagship-Meetings/12017-Rare-Diseases.aspx">U.S. Conference on Rare Diseases and Orphan Products</a> (DIA)</p>
<p><strong>October 24-26, 2012, Philadelphia, PA –</strong> <a target="_blank" href="http://www.gtcbio.com/component/conference/?file=home&cn=Biotechnology+Transfer+&Commercialization_Conference=&cid=96">Biotechnology Transfer &amp; Commercialization</a></p>
<p><strong>October 27-31, 2012, San Francisco, CA – </strong>American Public Health Association 140th <a target="_blank" href="http://www.apha.org/meetings/annualmeeting">Annual Meeting &amp; Expo</a></p>
<p><strong>October 30-November 1, 2012, Washington, DC – </strong><a target="_blank" href="http://www.ibclifesciences.com/WCB/overview.xml">Well Characterized Biologicals</a></p>
<p><strong>November 5-6, 2012, London, UK –</strong> <a target="_blank" href="http://www.cellculture-congress.com/">Cell Culture &amp; Bioprocessing Conference 2012</a></p>
<p><strong>November 5-6, 2012, Philadelphia, PA – </strong><a target="_blank" href="http://www.healthtech.com/proof-of-concept">Accelerating Proof-of-Concept</a></p>
<p><strong>November 11-15, 2012, Boston, MA –</strong> <a target="_blank" href="http://www.drugstomarket.com/harvarddrugbootcamp/">Drug Development Boot Camp</a>, Harvard University Office of Technology Development</p>
<p><strong><strong>November 13-16, 2012, Logan, UT –</strong> <a target="_blank" href="http://www.biosystems.usu.edu/htm/education/bioprocessing-programs/vaccine-production">Cell-Based Vaccine Production</a>:</strong><strong> A Hands-On Approach </strong></p>
<p><strong>November 26-27, 2012, Mumbai, India –</strong> <a target="_blank" href="http://www.terrapinn.com/conference/biopharma-india-convention/index.stm">BioPharma India Convention 2012</a> – speaker applications now being accepted</p>
<p><strong><a target="_blank" href="http://www.chi-peptalk.com/peptalk_content.aspx?id=91732"><img style="float: right; margin: 10px;" alt=" Renaissance Hotel and Palm Springs Convention Center, Palm Springs, CA (Photo courtesy of Renaissance Hotel)" src="http://assets1.csc.com/dvc/images/RenaissancePalmSpringsHotel.gif" height="167" width="250" /></a>December 5-7, 2012, San Diego, CA –</strong> <a target="_blank" href="http://www.bioconferences.com/Conferences/DNA/index.aspx">DNA Vaccines 2012</a>, 20th anniversary meeting</p>
<p><strong>January 21-25, 2013, Palm Springs, CA –</strong> <a target="_blank" href="http://www.chi-peptalk.com/">Pep Talk</a>: The Protein Science Week – now accepting <a target="_blank" href="http://www.chi-peptalk.com/peptalk_content.aspx?ekfrm=116231">speaker applications</a></p>
<p><strong>February 5-7, 2013, Miami, FL – </strong>4th Annual Summit for Clinical Ops Executives (<a target="_blank" href="http://www.scopesummit.com/">SCOPE</a>)</p>
<p><strong>February 11-12, 2013, San Francisco, CA – </strong>Genomics in Medicine (part of <a target="_blank" href="http://www.triconference.com/mmtc_content.aspx?id=107638">Molecular Med Tri-Con</a>) - <a target="_blank" href="http://www.triconference.com/mmtc_content.aspx?ekfrm=116905">speaker proposals</a> now being accepted</p>
<p><strong>March 5-7, 2012, Pune, India –</strong> <a target="_blank" href="http://www.imapac.com/index.php?page=VaccineWorldSummitIndia2013">Vaccine World Summit India 2013</a> – <a target="_blank" href="http://www.imapac.com/index.php?page=VaccineWorldSummitIndia2013Enquiry">speaker abstracts</a> now being accepted</p>
<p><strong>March 11-13, 2012, Rosslyn, VA – </strong>International Society for BioProcess Technology ISBioTech 3rd Annual Meeting, including Baculovirus Expression Technology and Viral Vectors &amp; Vaccines tracks - call for papers and posters now open</p>
<p><strong>March 18-21, 2013, Marina Bay Sands, Singapore – </strong><a target="_blank" href="http://www.terrapinn.com/exhibition/biopharma-asia/index.stm">6th Annual BioPharma Aisa Convention</a> - now accepting <a target="_blank" href="http://www.terrapinn.com/template/live/documents.aspx?e=5476&d=6996">speaker applications</a></p>
<p><strong>April 22-24, 2013, Baltimore, MD – </strong>NFID 16th Annual <a target="_blank" href="http://www.cvent.com/events/16th-annual-conference-on-vaccine-research/event-summary-db97bedd5ee041eeb09d971650f76be0.aspx">Conference on Vaccine Research</a> - <a target="_blank" href="http://www.cvent.com/events/16th-annual-conference-on-vaccine-research/custom-19-db97bedd5ee041eeb09d971650f76be0.aspx">Speaking opportunities</a>: travel grant abstracts are due<strong> November 27, 2012</strong> and general abstracts are due <strong>December 21, 2012</strong></p>
<p><strong>April 22-25, 2013, Chicago, IL –</strong> <a target="_blank" href="http://convention.bio.org/">BIO International Convention</a></p>
<p><strong>April 29-May 3, 2013, Boston, MA – </strong><a target="_blank" href="http://www.pegsummit.com/">9th Annual PEGS</a>, the Essential Protein Engineering Summit - <a target="_blank" href="http://www.pegsummit.com/pegs_content.aspx?ekfrm=118251">speaker proposals</a> due <strong>October 5, 2012</strong></p>
<p><strong>June 23-27, 2013, Boston, MA –</strong> <a target="_blank" href="http://www.diahome.org/en/Meetings-and-Training/Find-Meetings-and-Training/Meeting-Details.aspx?ProductID=30075&EventType=Annual%20Meeting">DIA 49th Annual Meeting</a> - Advancing Therapeutic Innovation and Regulatory Science</p>
<hr />
<h2><strong>Work With Us</strong></h2>
<p><a target="_blank" href="../../ds/11646/15183-dvc_fact_sheet.html"><img style="float: right; margin: 10px;" alt=" Stethoscope and question mark" src="http://assets1.csc.com/dvc/images/stethoscope_question.gif" height="150" width="100" /></a>Developing medical countermeasures is complicated. Here we offer <a href="../../ds/11646/15183-dvc_fact_sheet.html">answers to the questions</a> we hear most often.</p>
<p><strong>Team with us: </strong>DynPort can help you apply your technology to new programs, or advance your product from proof-of-concept into clinical trials. <a target="_blank" href="../../ds/16190/16326-team_with_dvc.html">Learn more</a></p>
<p><strong>Jobs</strong>: We're currently <a target="_blank" href="../../ds/16321/16362-job_openings.html">hiring</a> for two positions in Frederick, Maryland: Biotechnology Project Manager and Regulatory Affairs Manager.</p>
<hr />
<p><a target="_blank" href="http://twitter.com/dynport"><img src="http://assets1.csc.com/dvc/images/twitter2.png" alt="Follow us on Twitter" height="27" width="160" /></a> <a target="_blank" href="http://www.linkedin.com/company/dynport-vaccine-company-llc-a-csc-company"><img src="http://assets1.csc.com/dvc/images/linkedin.png" alt="Follow us on LinkedIn" height="27" width="158" /></a> <a target="_blank" href="../28826-bugs_and_drugs.html"><img src="http://assets1.csc.com/dvc/images/Blog_Button_small.jpg" alt="DVC Bugs and Drugs Blog" height="27" width="160" /></a></p>
<p> </p>
<p>View previous editions of this newsletter in our <a target="_blank" href="../41185-dvc_news_updates_for_partners.html">archive</a> or learn more about DVC on our <a target="_blank" href="../../../dvc.html">website</a>.</p>
<p>Like this newsletter? Plan to attend one of the events above? Have an idea for a topic we should cover? Let us know in the comments below!</p>
<p><em>DVC is not necessarily affiliated with third parties listed in this newsletter, nor does linking imply endorsement. The information herein is provided as a service for informational purposes only.</em></p>
<p>We'd love to hear from you! Feel free to comment below. Due to corporate policy, comments are moderated--we approve them during business hours Monday through Friday.</p>
<div id="_mcePaste" style="position: absolute; width: 1px; height: 1px; overflow: hidden; top: 0px; left: -10000px;">How to get more from your trade show investment</div></p>
    </section>
    </article>
		<div id="gigyaReactionsHolder"></div>


<div id="commentsPrefix"><div>COMMENTS</div></div>
<div id="gigyaSpecificityOverloader" class="gso"><div id="gigyaCommentsHolder"></div></div>


<script>
var delayedLoadComments = function () {
  //Setting up some vars used by all of the following Gigya plugins
  var defaultUserAction = new gigya.socialize.UserAction();
  defaultUserAction.setTitle(document.title);
  defaultUserAction.setLinkBack(window.location);

  var urlParts = window.location.pathname.split('/');
  var urlSlug = urlParts[urlParts.length -1].split('#')[0].split('?')[0];


  //########START REACTIONS########
  var textReactions=[
    {
      text: '',
      ID: 'thumbs_up',
      iconImgUp:'/images/new/icons/reaction_icons-thumbs_up.png',
      iconImgOver:'/images/new/icons/reaction_icons-thumbs_up.png',
      tooltip:'I give this article my thumbs up!',
      feedMessage: 'Thumbs Up!',
      headerText:'You give this article a thumbs up'
    }
    ,{
      text: '',
      ID: 'thumbs_down',
      iconImgUp:'/images/new/icons/reaction_icons-thumbs_down.png',
      iconImgOver:'/images/new/icons/reaction_icons-thumbs_down.png',
      tooltip:'I give this article my thumbs down.',
      feedMessage: 'Thumbs Down',
      headerText:'You give this article a thumbs down'
    }
  ];
  // Step 3: Define the Reactions Plugin's params object
  var reactionParams ={
    disabledProviders: 'twitter',
    barID: urlSlug, //  Identifier of the content to which this reaction refers
    containerID: 'gigyaReactionsHolder',  // Reactions Plugin DIV Container
    reactions: textReactions,  // The reaction array from Step 1
    userAction: defaultUserAction,  // The UserAction object from Step 2
    bodyText: 'Share it with your friends:', // optional - text that appears in the Share popup
    showCounts: 'top', // optional - displays the counters on top of the buttons
    cid:'',
    onReactionClicked:gigyaEventHandlers.onReactionClicked,
    onSendDone:gigyaEventHandlers.onSendDone
  };
  // Step 4: Load the Reactions Plugin:
  gigya.socialize.showReactionsBarUI(reactionParams);
  //########END REACTIONS########

  
  //########START COMMENTS########
  var commentsTemplates = {
    loginCanvas_loggedIn: '<div class="gig_photoHolder">$photoDiv</div><div class="gig_username">$username</div><div class="gig_logout"><a href="/utils/logout_visitor">Log&nbsp;Out</a></div>',
    loginCanvas_loggedOut:'<div class="gig_photoHolder"><img src="/images/new/icons/comment_default_user_icon.png" width="48" height="48" alt=""></div><div class="gig_loginmessage"><h3>Post a new comment</h3><p>You must be logged in to post comments.</p></div><div class="gig_login"><a href="javascript:void(0);" onclick="accountPopupWindow(\'account_login\');"><img src="/images/new/icons/comment_login_button.png" width="144" height="24" alt="Login"></a></div>'
  };
  //Good browsers get '100%', and Gigya's internals turn this number plus some math into 'NaNpx',
  //which is applied to the `width` value of the style attribute on EVERY ELEMENT GIGYA TOUCHES.
  //As 'NaNpx' is an invalid CSS width value, all of Gigya's width values fail, and mine take precedence.
  //IE7 & 8 try someElement.style.width = (NaN) + 'px' and error out, breaking the whole showCommentsUI invocation.
  //No responsive comments for IE7 or 8!
  var gigyaCommentsWidth = '100%';
  if($.browser.msie === true && ($.browser.version === '8.0' || $.browser.version === '7.0')){
    gigyaCommentsWidth = 640;
  }
  var showCommentsParams ={
    categoryID: "Unmoderated",
    streamID: "89381",
    useSiteLogin: true,
    onSiteLoginClicked: gigyaEventHandlers.onSiteLoginClicked,
    containerID: 'gigyaCommentsHolder',
    cid:'',
    templates: commentsTemplates,
    width:gigyaCommentsWidth,
    enabledShareProviders: 'facebook,yahoo,linkedin,pinterest',
    onSendDone: gigyaEventHandlers.onSendDone,
    onCommentSubmitted: gigyaEventHandlers.onCommentSubmitted,
    onLoad:function(){
      if(mobileDevice){
        myScroll.refresh();
      }
    }
  }
  gigya.socialize.showCommentsUI(showCommentsParams);
  //########END COMMENTS########
  
}
$csc().gigya.register(delayedLoadComments);
</script>
    </article>

  <aside class="sideBar">        
      <div>
        Welcome! Thanks for checking out news for our partners from
DynPort Vaccine Company LLC, a CSC company.<br><br>

We’ve been working in biopharmaceutical product development as a
government contractor since 1997, and have learned a few things along
the way. <strong>But... this newsletter isn't about us. </strong> <br><br>

Our goal is to share information with our partners and
potential partners, who may be interested in developments related to
government contracting and biopharmaceuticals.  (We send updates no more than once a month, so no need to worry about us overwhelming your inbox!)<br><br>

<strong>To receive these updates via email, <a href="../../ds/16190/41114-join_our_partners_e_mail_list.html"><strong>sign up here</strong></a>.</strong>  
      </div>
    </aside>
     </div>
</section>
      
<aside id="myRcmds">
  <header id="myRcmdsHeader">
    <div id="myRcmdsPersHeader"><strong>CSC Recommendations</strong></div>
    <div id="myRcmdsPersonalization">
      <div id="persIcon"><img src="../../../images/new/icons/comment_default_user_icon.png" alt=""></div>
      <div id="persButtons">
        <ul>
          <li id="myrecs_logout"><a href="../../../utils/logout_visitor.html">LOG OUT</a></li>
          <li id="myrecs_edit"><a onclick="accountPopupWindow('editprofile');" href="javascript:void(0);">EDIT PROFILE</a></li>
        </ul>
      </div>
      <div id="persProfile"><span id="myrecs_visitor_name"></span><span id="myrecs_job_title"></span></div>
    </div>
  </header>
  <div id="myRcmdsTrigger"><a id="myRcmdsChevronHolder"><span id="myRcmdsChevron">&laquo;</span></a></div>
  <section id="recs_content">
    <label>Recommended Reading</label>
    <div id="recs_div">

      <article class="contentNode">
        <a class="imgAnchor" href="../../../application_services/success_stories/78846-coca_cola_supply_chain_management_success_story-ref=rec&dyn=0.html"><img src='../../../images/Px_Clear.gif' class='rec_success' height="50" width="50" alt="Coca-Cola Supply Chain Management Success Story" /></a>
        <section class="textArea"><strong class="headline"><a href="../../../application_services/success_stories/78846-coca_cola_supply_chain_management_success_story-ref=rec&dyn=0.html">Coca-Cola Supply Chain Management Success Story</a></strong><p>Coca-Cola has dominated the beverage market for over a century, yet still values...</p></section>
      </article>

      <article class="contentNode">
        <a class="imgAnchor" href="../../../innovation/insights/92142-the_future_of_3d_printing_services_and_manufacturing-ref=rec&dyn=0.html"><img src='../../../images/Px_Clear.gif' class='rec_insight' height="50" width="50" alt="The Future of 3D Printing Services and Manufacturing " /></a>
        <section class="textArea"><strong class="headline"><a href="../../../innovation/insights/92142-the_future_of_3d_printing_services_and_manufacturing-ref=rec&dyn=0.html">The Future of 3D Printing Services and Manufacturing </a></strong><p>CSC explores the future of 3D printing and manufacturing, as 3D printing manufacturing...</p></section>
      </article>

      <article class="contentNode">
        <a class="imgAnchor" href="../../../about_us/insights/98905-our_strategy_moving_forward-ref=rec&dyn=0.html"><img src='../../../images/Px_Clear.gif' class='rec_insight' height="50" width="50" alt="Our Strategy: Moving Forward" /></a>
        <section class="textArea"><strong class="headline"><a href="../../../about_us/insights/98905-our_strategy_moving_forward-ref=rec&dyn=0.html">Our Strategy: Moving Forward</a></strong><p>This past year, CSC launched a full-scale turnaround to elevate our business performance...</p></section>
      </article>

      <article class="contentNode">
        <a class="imgAnchor" href="../../../infrastructure_services/offerings/52117/52450-self_service-ref=rec&dyn=0.html"><img src='../../../images/Px_Clear.gif' class='rec_offer' height="50" width="50" alt="Self Service" /></a>
        <section class="textArea"><strong class="headline"><a href="../../../infrastructure_services/offerings/52117/52450-self_service-ref=rec&dyn=0.html">Self Service</a></strong><p>An innovative, ITIL-aligned portfolio of self help services that helps you manage...</p></section>
      </article>

    </div>
  </section>
</aside>
<script type="text/javascript">
  var f = true;
  var myrecs_rec = 'recs_item_va';
  var myrecs_param = 'entity.id=89381';
</script>

      <!-- Content End -->
      <footer>
        <div class="wrapper">

          <section id="relationsBucket">
            <nav>
              <ul>
                <li><a class="redTri" href="../../../about_us.html"><strong>ABOUT CSC</strong></a>
                </li>
                <li><a class="blueTri" href="../../../success_stories.html"><strong>SUCCESS STORIES</strong></a>
                </li>
                <li><a class="lightBlueTri" href="../../../careersus/flxwd/16005-careers.html"><strong>CAREERS</strong></a>
                </li>
                <li><a class="purpleTri" href="../../../global_alliances.html"><strong>GLOBAL ALLIANCES</strong></a>
                </li>
                <li><a class="yellowTri" href="../../../newsroom.html"><strong>NEWSROOM</strong></a>
                </li>
                <li><a class="greenTri" href="../../../investor_relations.html"><strong>INVESTOR RELATIONS</strong></a>
                </li>
              </ul>
            </nav>
          </section>

          <section id="newsEventsBucket">
                        <strong class="headline">
              CSC WIRE</strong>
            <nav>
              <ul>
<li><a href='../../../investor_relations/press_releases/106413.html'>CSC Delivers Continued Earnings, Margin and Cash Flow Growth</a></li>
<li><a href='../../../newsroom/press_releases/105673-hcl_technologies_and_csc_announce_strategic_partnership_to_address_the_application_modernization_market.html'>HCL Technologies and CSC Announce Strategic Partnership to Address the Application Modernization Market</a></li>
<li><a href='../../../newsroom/press_releases/105677-csc_to_host_investor_call_to_discuss_strategic_partnership_with_hcl_technologies_on_wednesday_january_15_2014.html'>CSC Hosts Investor Call to Discuss Strategic Partnership with HCL Technologies</a></li>

              </ul>
            </nav>
          </section>

          <section id="contactBucket">
            <div class="thumbBucket">
  <strong class="headline">
    Engage With Us</strong>
  <!-- comment to hide this section and reveal the following section -->

 <section>
    <aside>
      <a href="../../../townhall.html" class="townHall">
	  </a>
    </aside>
    <article class="doubleLine">
      <a href="../../../townhall.html">View On-Demand <br>Town Hall Events</a>
    </article>
  </section> 

  <!-- end townhall section -->
  <!-- uncomment following content for where there is a town hall.  Be sure to specify event title and include ref=blinkgif. -->
<!-- 
    <section>
    <aside>
      <a href="/townhall/events/105269-how_will_regulatory_changes_impact_disaster_recovery?ref=blinkgif" class="townHallLive">
	  </a>
    </aside>
    <article class="doubleLine">
      <a href="/townhall/events/105269-how_will_regulatory_changes_impact_disaster_recovery?ref=blinkgif"><span class='alert'>Live Now in the Town Hall</span><br />How Will Regulatory Changes Impact Disaster Recovery?</a>
    </article>
  </section>
-->
  <!-- end live townhall section -->
  <section class="lef">
    <aside>
      <a href="../../../innovation.html" class="feedback">
        <!--img src="/images/new/icons/feedback.png" alt="Subscribe to our Newsletters" /--></a>
    </aside>
    <article>
      <a href="javascript:void(0);" onclick="premiumContentPopupWindow({id: '7829', mediaType: 'newsletter', type: ''}); ">Get our Newsletters</a><br />
     </article>
  </section>

  <section>
    <aside>
      <a href="../../../engage_communities.html" class="community">
        <!--img src="/images/new/icons/communities.png" alt="CSC Communities" /--></a>
    </aside>
    <article>
      <a href="../../../engage_communities.html"> Join our Communities</a>
    </article>
  </section>

  <section class="feedbackSection">
    <aside>
      <a href="javascript:void(0);" onclick="surveyPopupWindow('http://survey.omniture.com/d1/hosted/b22135be47','',1000,600);" id="engageWithUs" class="lef">
        <!--img src="/images/new/icons/forums.png" alt="Feedback" /--></a>
    </aside>
    <article>
      <a href="javascript:void(0);" onclick="surveyPopupWindow('http://survey.omniture.com/d1/hosted/b22135be47','',1000,600);">Give Your Feedback</a>
    </article>
  </section>
</div>
          </section>

          <section id="socialBucket">
            <strong class="headline">
              Follow Us</strong>
            <nav class="social footer">
              <!-- Follow Bar plugin DIV container -->
              <div id="gigyaFollowFooter"></div>
              <div id="gigyaFollowFooterMobile">
                <ul>
                  <li><a href="http://www.facebook.com/pages/CSC/51414306171?v=app_101332539959471" class="facebook" target="_blank">&nbsp;</a></li>
                  <li><a href="http://twitter.com/#!/CSCNews" class="twitter" target="_blank">&nbsp;</a></li>
                  <li><a href="http://www.linkedin.com/company/csc" class="linkedin" target="_blank">&nbsp;</a></li>
                  <li><a href="../../../feeds.html" class="rss" target="_blank">&nbsp;</a></li>
                  <li><a itemprop="publisher" href="https://plus.google.com/118416213869891352236" class="googleplus clearText" target="_blank">CSC</a></li>
                </ul>
              </div>
              <ul>
                <li>
                  <a href="http://www.youtube.com/user/csc" target="_blank" class="youtube clearText">&nbsp;</a>
                </li>
              </ul>
            </nav>
          </section>
          <section id="corpBucket">
            <nav class="corpInfo">
              <ul>
  <li><a href="../../../legal.html">Legal</a>&nbsp;|&nbsp; </li>
  <li><a href="../../../privacy.html">Privacy</a>&nbsp;|&nbsp; </li>
  <li><a href="../../../site_map.html">Site Map</a>&nbsp; </li>
  <li>&copy; Computer Sciences Corp </li>
</ul>

            </nav>
          </section>
        </div>
      </footer>
    </div>
  </div>
  <!-- scripts -->
  <script type="text/javascript" src="http://www.google.com/jsapi?key=ABQIAAAAmQdrOgG-5AIXvyPvLF37UxSkoY0ZZixtVMJANGkGJlQelbG63hREfyZFOAPj93RuUqgytyCufo6x5Q">
</script>

<script type="text/javascript" src="http://assets2.csc.com/javascripts/googlefeedfetcher.js">

/***********************************************
* gAjax RSS Feeds Displayer- (c) Dynamic Drive (www.dynamicdrive.com)
* This notice MUST stay intact for legal use
* Visit http://www.dynamicdrive.com/ for full source code
***********************************************/

</script>

<style type="text/css">

.labelfield{ /*CSS for label field in general*/
color:brown;
font-size: 90%;
}

.datefield{ /*CSS for date field in general*/
color:gray;
font-size: 90%;
}

#example1 li{ 
margin-bottom: 8px;
padding-bottom: 8px;
margin-left:-28px;
text-indent:0px;
}
</style>
  <!-- end of scripts -->
  
</div>
 <script src="../../../javascripts/user/twistage_omniture-min-19b876fa394902ce781dfc20f23ba899.js" type="text/javascript"></script>
 <img src="http://a.company-target.com/pixel?id=1372868710&type=js" alt="pixel" style="display:none"/>
<img src="http://a.company-target.com/pixel?id=1372868656&type=js" alt="pixel" style="display:none"/>
 <script type="text/javascript">
    var _elqQ = _elqQ || [];
    _elqQ.push(['elqSetSiteId', '3015']);
    _elqQ.push(['elqTrackPageView']);
    
    (function () {
        function async_load() {
            var s = document.createElement('script'); s.type = 'text/javascript'; s.async = true;
            s.src = '//img.en25.com/i/elqCfg.min.js';
            var x = document.getElementsByTagName('script')[0]; x.parentNode.insertBefore(s, x);
        }
        if (window.addEventListener) window.addEventListener('DOMContentLoaded', async_load, false);
        else if (window.attachEvent) window.attachEvent('onload', async_load); 
    })();
</script>
</body>
</html>
